about
Three dimensional quantitative structure-activity relationship of 5H-Pyrido[4,3-b]indol-4-carboxamide JAK2 inhibitors.JAK2 inhibition for the treatment of hematologic and solid malignancies.Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.Emerging immunosuppressive drugs in myelodysplastic syndromes.Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer.MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.JAK Kinase Inhibitors as Possible Treatment for Myeloproliferative Disorders and Cancer: Patent HighlightQuantification of JAK2V617F mutation by next-generation sequencing technology.
P2860
Q37007281-FEBE5F07-4FC0-428D-9A16-F0514A9266CAQ38001733-025DE062-A252-4AA3-B39E-B39313D8A672Q38042734-1D4E4E87-999D-4B8A-959B-A5C8FE45799EQ38060835-A1549041-CCA8-4564-B0A8-D34438753120Q38167808-E95A0C79-2168-4FCF-8E96-9A9C81B1FCFDQ39400620-4F948CDC-ED7B-4CE9-B2FB-435A24E0FF93Q39731112-245E318D-02DF-4718-B845-2EEC1BC04A3AQ44186784-6C227010-D5E4-47D9-B5D2-7025682EA49F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New JAK2 inhibitors for myeloproliferative neoplasms.
@en
New JAK2 inhibitors for myeloproliferative neoplasms.
@nl
type
label
New JAK2 inhibitors for myeloproliferative neoplasms.
@en
New JAK2 inhibitors for myeloproliferative neoplasms.
@nl
prefLabel
New JAK2 inhibitors for myeloproliferative neoplasms.
@en
New JAK2 inhibitors for myeloproliferative neoplasms.
@nl
P2860
P1476
New JAK2 inhibitors for myeloproliferative neoplasms.
@en
P2093
Alfonso Quintás-Cardama
P2860
P304
P356
10.1517/13543784.2011.579560
P407
P577
2011-04-27T00:00:00Z